Atlas Trials

Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer

Clinical trial NCT01367002 · COMPLETED

Trial details

NCT number
NCT01367002
Sponsor
Yale University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Endometrial Cancer
Start date
2011-06-01
Primary completion
2022-06-30
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.